Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

This precipitous sell-off has placed Lilly stock near its lowest levels in six months. Below, I'll explore what's been driving the sell-off, and assess whether Lilly has any catalysts that could make ...

(RTTNews) - Eli Lilly and Co. (LLY) said that its board approved a new $15 billion share repurchase program. The company's prior $5 billion share repurchase program was completed in the fourth ...